advertisement
Frontiers in pharmacology 22
Showing records 1 to 22 | Display all abstracts in Frontiers in pharmacology90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Fiedorowicz M
Frontiers in pharmacology 2020; 11: 573238
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zhu X
Frontiers in pharmacology 2020; 11: 1006
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Li X
Frontiers in pharmacology 2020; 11: 1038
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Wełniak-Kamińska M
Frontiers in pharmacology 2020; 11: 573238
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Wu S
Frontiers in pharmacology 2020; 11: 1006
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Leng Y; Jiang Q
Frontiers in pharmacology 2020; 11: 1038
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Świątkiewicz M
Frontiers in pharmacology 2020; 11: 573238
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zeng W; Chen X
Frontiers in pharmacology 2020; 11: 1006
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang Z
Frontiers in pharmacology 2020; 11: 1038
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Orzeł J
Frontiers in pharmacology 2020; 11: 573238
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Luo P
Frontiers in pharmacology 2020; 11: 1038
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zheng T
Frontiers in pharmacology 2020; 11: 1006
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Chorągiewicz T
Frontiers in pharmacology 2020; 11: 573238
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Ren J
Frontiers in pharmacology 2020; 11: 1006
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Zhang C
Frontiers in pharmacology 2020; 11: 1038
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Toro MD
Frontiers in pharmacology 2020; 11: 573238
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Chen L
Frontiers in pharmacology 2020; 11: 1038
90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Ke M
Frontiers in pharmacology 2020; 11: 1006
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Rejdak R
Frontiers in pharmacology 2020; 11: 573238
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang Y
Frontiers in pharmacology 2020; 11: 1038
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Bogorodzki P; Grieb P
Frontiers in pharmacology 2020; 11: 573238
90780 Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats Activating AMPK/Nrf2 Signaling Pathway
Wang H; Yue X; Shen C; Zhou Y; Shi C; Xie L
Frontiers in pharmacology 2020; 11: 1038
